Yea why would we want to fund a phase 3? Oh we
Post# of 155492
Oh we let NASH go to a third party ? Who cares there’s only 1000009 other indications.
Yea I’m with management. Focus on the BLA and look for partnerships for the other trials we need to do.
Almost all of are problems can be solved once the BLA is completed. We will know more before the year is over. It’s actually possible it gets filed this year.
So yes nobody wants more shares issued. But who knows we might not even use them. If we don’t authorize more shares then we are in a bad spot to negotiate.
I think we are in a great spot to negotiate as long as the lights are on. We have two trials that hit end points this year. mTNBC and NASH. One or both will most definitely get a partners. That’s a no brainer. Don’t let people convince you that this isn’t on the table. I call bullshit.
We also have the basket trial that’s almost done correct?


CytoDyn Inc (CYDY) Stock Research Links
Federal Whistleblower / Special Operations Tactical Unit
USAF: Phoenix Raven #2143
HHS & SEC Whistleblower: HL-1412396
DOJ Investigation Report/ Whistleblower ID: 20250705-0001
Founder & CEO of FireGate Bioscience
USPTO: Lead Inventor of the HIV Cure & AI Federal Oversight Program
⸻
Public Links
FireGate Bioscience: https://www.firegatebioscience.com
NotYourDrug.com: https://www.notyourdrug.com